Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC Article

Arasada, Rajeswara Rao, Shilo, Konstantin, Yamada, Tadaaki et al. (2018). Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC . 9 10.1038/s41467-018-05626-2

Open Access International Collaboration

cited authors

  • Arasada, Rajeswara Rao; Shilo, Konstantin; Yamada, Tadaaki; Zhang, Jianying; Yano, Seiji; Ghanem, Rashelle; Wang, Walter; Takeuchi, Shinji; Fukuda, Koji; Katakami, Nobuyuki; Tomii, Keisuke; Ogushi, Fumitaka; Nishioka, Yasuhiko; Talabere, Tiffany; Misra, Shrilekha; Duan, Wenrui; Fadda, Paolo; Rahman, Mohammad A; Nana-Sinkam, Patrick; Evans, Jason; Amann, Joseph; Tchekneva, Elena E; Dikov, Mikhail M; Carbone, David P

sustainable development goals

authors

publication date

  • August 10, 2018

keywords

  • ACQUIRED-RESISTANCE
  • CELL LUNG-CANCER
  • GEFITINIB
  • GROWTH
  • INHIBITION
  • Multidisciplinary Sciences
  • NOTCH3
  • PATHWAY
  • RECEPTOR GENE-MUTATIONS
  • STEM-CELLS
  • Science & Technology
  • Science & Technology - Other Topics
  • WNT

Digital Object Identifier (DOI)

publisher

  • NATURE PORTFOLIO

volume

  • 9